Nesivine Pédiatrie Sine Conservans (Oxymetazoline Hydrochloride)

Oxymetazoline selectively activates alpha‑1 adrenergic receptors on the smooth muscle of nasal blood vessels. This causes the vessels to constrict, reducing blood flow and swelling in the nasal mucosa, which opens the airway and eases the feeling of blockage.

The appropriate dose and frequency are determined by a qualified healthcare professional based on the patient’s age, weight, and severity of symptoms. Patients should follow the prescriber’s instructions and the product label carefully.

Safety data for oxymetazoline in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using the product.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Nesivine’s active ingredient, oxymetazoline, is a selective alpha‑adrenergic agonist, offering rapid onset of action and a relatively short duration compared with some longer‑acting agents like phenylephrine. It is commonly preferred for short‑term relief due to its efficacy and established safety profile when used as directed.

Store the product at temperatures below 25 °C, in its original packaging, protected from moisture and direct sunlight. Keep the container tightly closed when not in use to maintain product integrity.

The medication is applied intranasally as a spray. The prescribed number of sprays per nostril is administered according to the healthcare professional’s guidance, typically not exceeding the recommended frequency to avoid rebound congestion.

Serious risks, though rare, include elevated blood pressure, cardiac palpitations, and severe nasal irritation or ulceration. Users should seek immediate medical attention if they experience persistent hypertension, chest pain, or signs of an allergic reaction.

Individuals with known hypersensitivity to oxymetazoline or any formulation component should avoid the product. It is also contraindicated in patients with severe hypertension, certain cardiovascular disorders, or those taking monoamine oxidase inhibitors without medical supervision.